Pharmacological and rAAV gene therapy rescue of visual functions in a blind mouse model of leber congenital amaurosis

被引:105
作者
Batten, ML
Imanishi, Y
Tu, DC
Doan, T
Zhu, L
Pang, JJ
Glushakova, L
Moise, AR
Baehr, W
Van Gelder, RN
Hauswirth, WW
Rieke, F
Palczewski, K [1 ]
机构
[1] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA
[2] Case Western Reserve Univ, Case Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA
[3] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA
[4] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA
[5] Univ Washington, Dept Chem, Seattle, WA 98195 USA
[6] Univ Florida, Dept Ophthalmol, Gainesville, FL USA
[7] Univ Florida, Powell Gene Therapy Ctr, Gainesville, FL USA
[8] Univ Utah, Dept Ophthalmol, Salt Lake City, UT USA
[9] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA
[10] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT USA
[11] Washington Univ, Sch Med, Dept Mol Biol, St Louis, MO USA
[12] Washington Univ, Sch Med, Dept Pharmacol, St Louis, MO 63110 USA
[13] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA
关键词
D O I
10.1371/journal.pmed.0020333
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Leber congenital amaurosis (LCA), a heterogeneous early-onset retinal dystrophy, accounts for similar to 15% of inherited congenital blindness. One cause of LCA is loss of the enzyme lecithin:retinol acyl transferase (LRAT), which is required for regeneration of the visual photopigment in the retina. Methods and Findings An animal model of LCA, the Lrat(-/-) mouse, recapitulates clinical features of the human disease. Here, we report that two interventions-intraocular gene therapy and oral pharmacologic treatment with novel retinoid compounds-each restore retinal function to Lrot(-/-) mice. Gene therapy using intraocular injection of recombinant adeno-associated virus carrying the Lrat gene successfully restored electroretinographic responses to similar to 50% of wildtype levels (p < 0.05 versus wild-type and knockout controls), and pupillary light responses (PLRs) of Lrat(-/-) mice increased similar to 2.5 log units (p < 0.05). Pharmacological intervention with orally administered pro-drugs 9-cis-retinyl acetate and 9-cis-retinyl succinate (which chemically bypass the LRAT-catalyzed step in chromophore regeneration) also caused long-lasting restoration of retinal function in LRAT-cleficient mice and increased ERG response from similar to 5% of wild-type levels in Lrat(-/-) mice to similar to 50% of wild-type levels in treated Lrat(-/-) mice (p < 0.05 versus wild-type and knockout controls). The interventions produced markedly increased levels of visual pigment from undetectable levels to 600 pmoles per eye in retinoid treated mice, and similar to 1,000-fold improvements in PLR and electroretinogram sensitivity. The techniques were complementary when combined. Conclusion Intraocular gene therapy and pharmacologic bypass provide highly effective and complementary means for restoring retinal function in this animal model of human hereditary blindness. These complementary methods offer hope of developing treatment to restore vision in humans with certain forms of hereditary congenital blindness.
引用
收藏
页码:1177 / 1189
页数:13
相关论文
共 55 条
[1]   Gene therapy restores vision in a canine model of childhood blindness [J].
Acland, GM ;
Aguirre, GD ;
Ray, J ;
Zhang, Q ;
Aleman, TS ;
Cideciyan, AV ;
Pearce-Kelling, SE ;
Anand, V ;
Zeng, Y ;
Maguire, AM ;
Jacobson, SG ;
Hauswirth, WW ;
Bennett, J .
NATURE GENETICS, 2001, 28 (01) :92-95
[2]   Impairment of the transient pupillary light reflex in Rpe65-/- mice and humans with Leber congenital amaurosis [J].
Aleman, TS ;
Jacobson, SG ;
Chico, JD ;
Scott, ML ;
Cheung, AY ;
Windsor, EAM ;
Furushima, M ;
Redmond, TM ;
Bennett, J ;
Palczewski, K ;
Cideciyan, AV .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 (04) :1259-1271
[3]   The retinoid cycle and retina disease [J].
Baehr, W ;
Wu, SM ;
Bird, AC ;
Palczewski, K .
VISION RESEARCH, 2003, 43 (28) :2957-2958
[4]   Lecithin-retinol acyltransferase is essential for accumulation of all-trans-retinyl esters in the eye and in the liver [J].
Batten, ML ;
Imanishi, Y ;
Maeda, T ;
Tu, DC ;
Moise, AR ;
Bronson, D ;
Possin, D ;
Van Gelder, RN ;
Baehr, W ;
Palczewski, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (11) :10422-10432
[5]  
BAYLOR DA, 1987, INVEST OPHTH VIS SCI, V28, P34
[6]   Strange vision: ganglion cells as circadian photoreceptors [J].
Berson, DM .
TRENDS IN NEUROSCIENCES, 2003, 26 (06) :314-320
[7]  
BOK D, 1985, INVEST OPHTH VIS SCI, V26, P1659
[8]   Gene therapy for retinal and choroidal diseases [J].
Campochiaro, PA .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2002, 2 (05) :537-544
[9]   A decade of molecular biology of retinoic acid receptors [J].
Chambon, P .
FASEB JOURNAL, 1996, 10 (09) :940-954
[10]   Teratology of retinoids [J].
Collins, MD ;
Mao, GE .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 :399-430